Japan to design personalized cancer vaccine

Transgene, a biotech company in Tokyo that designs and develops virus-based immunotherapies for the treatment of cancer,...

May 15, 2020 | Friday | News
Moderna's COVID-19 vaccine enters Ph 2 trial

US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...

May 14, 2020 | Thursday | News
Pfizer, BioNTech initiate human trials with COVID-19 mRNA Vaccine

Pfizer Inc. and BioNTech SE  announced on 5 May 2020 that the first participants have been dosed in the U.S. in the...

May 7, 2020 | Thursday | News
CEPI invests $3.5M in Clover Australia for COVID-19 vaccine

Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...

May 1, 2020 | Friday | News
NanoPass joins pharma partners for COVID-19 vaccine development

Novel Coronavirus presents a global pandemic with unprecedented medical, economic and social scales. Since there is curr...

April 27, 2020 | Monday | News
CanSino Bio enrols for Ph 2 trial of COVID-19 vaccine

China’s CanSino Biologics advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making this vaccine c...

April 27, 2020 | Monday | News
NEC designs blueprints for COVID-19 vaccines using AI

Japan based NEC Corporation has announced analysis results from efforts using AI prediction platforms to design blueprin...

April 24, 2020 | Friday | News
Inovio to begin Ph 1/2 clinical trial of COVID-19 vaccine

South Korea based International Vaccine Institute (IVI) has announced that the Coalition for Epidemic Preparedness Innov...

April 20, 2020 | Monday | News
Three Chinese vaccines against COVID-19 are on the way

According to the latest news from Science and Technology Daily, two COVID-19 inactivated vaccines were just approved f...

April 17, 2020 | Friday | News
India, Australia partner to develop vaccine for COVID-19

Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company, has announced that the company is going t...

April 8, 2020 | Wednesday | News
CSIRO begins testing COVID-19 vaccines

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...

April 2, 2020 | Thursday | News
Medicago announces production of viable vaccine candidate for COVID-19

Medicago, a biopharmaceutical company headquartered in Quebec City, Canada has announced that they have successfully pro...

March 27, 2020 | Friday | News
Novavax, Serum Institute of India to co-develop malaria Vaccine

Novavax and Serum Institute of India (SII) has announced a commercial license agreement for the use of Novavax’ pr...

March 17, 2020 | Tuesday | News
CEPI expands investment in COVID-19 vaccine development

CEPI, the Coalition for Epidemic Preparedness Innovations, on 10 March 2020 announced the expansion of its COVID-19 vacc...

March 11, 2020 | Wednesday | News
SII expects human trials for COVID-19 vaccine in 6 months

Serum Institute of India Pvt. Ltd. (SIIPL), the world's largest vaccine manufacturer by number of doses produced and sol...

February 20, 2020 | Thursday | News
NUS works on COVID-19 vaccine trial and rapid test kits

Scientists from the National University of Singapore (NUS) community are working on a vaccine trial and rapid detection ...

February 19, 2020 | Wednesday | News
WuXi Vaccines to build integrated manufacturing facility

WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologi...

February 18, 2020 | Tuesday | News
Pfizer Vaccines launches global centers of excellence network

Pfizer Inc. has announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of...

January 24, 2020 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls